tiprankstipranks
Trending News
More News >
Grand Pharmaceutical Group Limited (HK:0512)
:0512
Hong Kong Market
Advertisement

Grand Pharmaceutical Group Limited (0512) Ratios

Compare
4 Followers

Grand Pharmaceutical Group Limited Ratios

HK:0512's free cash flow for Q2 2025 was HK$0.59. For the 2025 fiscal year, HK:0512's free cash flow was decreased by HK$ and operating cash flow was HK$0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.20 1.22 1.07 1.22 1.24
Quick Ratio
0.99 0.98 0.86 1.02 1.01
Cash Ratio
0.07 0.23 0.22 0.32 0.43
Solvency Ratio
0.28 0.31 0.30 0.36 0.37
Operating Cash Flow Ratio
0.25 0.42 0.30 0.38 0.41
Short-Term Operating Cash Flow Coverage
0.60 1.05 0.59 1.00 1.13
Net Current Asset Value
HK$ -1.15BHK$ -228.66MHK$ -1.28BHK$ -835.58MHK$ -321.18M
Leverage Ratios
Debt-to-Assets Ratio
0.17 0.15 0.20 0.17 0.14
Debt-to-Equity Ratio
0.27 0.22 0.32 0.27 0.21
Debt-to-Capital Ratio
0.21 0.18 0.24 0.21 0.18
Long-Term Debt-to-Capital Ratio
0.09 0.06 0.08 0.10 0.07
Financial Leverage Ratio
1.54 1.49 1.58 1.57 1.51
Debt Service Coverage Ratio
0.84 1.00 0.79 1.23 1.26
Interest Coverage Ratio
8.35 12.98 18.31 21.71 13.08
Debt to Market Cap
0.15 0.24 0.27 0.16 0.10
Interest Debt Per Share
1.37 1.03 1.30 1.05 0.73
Net Debt to EBITDA
1.48 0.70 0.98 0.61 0.22
Profitability Margins
Gross Profit Margin
57.64%61.96%62.24%61.03%63.52%
EBIT Margin
19.49%24.21%27.76%33.48%34.46%
EBITDA Margin
23.89%28.17%32.35%36.11%38.00%
Operating Profit Margin
12.44%25.29%26.33%23.48%23.76%
Pretax Profit Margin
20.23%22.26%26.78%31.08%31.66%
Net Profit Margin
17.77%17.85%21.75%27.94%28.22%
Continuous Operations Profit Margin
17.53%18.24%21.94%27.97%28.04%
Net Income Per EBT
87.80%80.20%81.21%89.92%89.12%
EBT Per EBIT
162.66%88.02%101.71%132.37%133.28%
Return on Assets (ROA)
7.86%8.35%9.30%11.41%10.55%
Return on Equity (ROE)
12.37%12.40%14.71%17.94%15.95%
Return on Capital Employed (ROCE)
7.36%15.87%15.82%13.03%11.90%
Return on Invested Capital (ROIC)
5.59%11.25%10.99%9.83%9.05%
Return on Tangible Assets
9.48%9.27%10.56%12.74%11.88%
Earnings Yield
7.05%13.40%12.76%10.48%7.56%
Efficiency Ratios
Receivables Turnover
2.94 0.00 4.33 4.00 3.70
Payables Turnover
3.07 3.01 4.14 4.56 3.50
Inventory Turnover
3.50 2.88 2.69 3.00 2.43
Fixed Asset Turnover
2.64 2.64 2.43 2.26 1.86
Asset Turnover
0.44 0.47 0.43 0.41 0.37
Working Capital Turnover Ratio
8.41 12.26 11.63 7.72 10.22
Cash Conversion Cycle
109.36 5.31 131.51 132.93 144.71
Days of Sales Outstanding
124.01 0.00 84.24 91.25 98.60
Days of Inventory Outstanding
104.31 126.54 135.50 121.69 150.44
Days of Payables Outstanding
118.96 121.23 88.23 80.01 104.33
Operating Cycle
228.32 126.54 219.74 212.94 249.04
Cash Flow Ratios
Operating Cash Flow Per Share
0.47 0.69 0.54 0.60 0.52
Free Cash Flow Per Share
0.31 0.55 0.07 0.42 0.38
CapEx Per Share
0.17 0.14 0.47 0.18 0.14
Free Cash Flow to Operating Cash Flow
0.65 0.79 0.13 0.70 0.74
Dividend Paid and CapEx Coverage Ratio
1.12 2.44 0.93 2.09 2.24
Capital Expenditure Coverage Ratio
2.83 4.87 1.15 3.38 3.80
Operating Cash Flow Coverage Ratio
0.36 0.71 0.43 0.58 0.74
Operating Cash Flow to Sales Ratio
0.14 0.23 0.20 0.25 0.28
Free Cash Flow Yield
3.64%13.74%1.51%6.52%5.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.18 7.46 7.84 9.54 13.22
Price-to-Sales (P/S) Ratio
2.52 1.33 1.70 2.67 3.73
Price-to-Book (P/B) Ratio
1.72 0.93 1.15 1.71 2.11
Price-to-Free Cash Flow (P/FCF) Ratio
27.48 7.28 66.29 15.33 18.11
Price-to-Operating Cash Flow Ratio
17.77 5.79 8.50 10.80 13.35
Price-to-Earnings Growth (PEG) Ratio
-0.90 -0.88 -0.59 0.31 0.27
Price-to-Fair Value
1.72 0.93 1.15 1.71 2.11
Enterprise Value Multiple
12.02 5.43 6.25 7.99 10.03
Enterprise Value
33.62B 16.10B 19.32B 24.81B 24.22B
EV to EBITDA
12.02 5.43 6.25 7.99 10.03
EV to Sales
2.87 1.53 2.02 2.89 3.81
EV to Free Cash Flow
31.33 8.35 78.62 16.59 18.51
EV to Operating Cash Flow
20.26 6.64 10.08 11.69 13.64
Tangible Book Value Per Share
3.64 3.71 3.25 3.17 2.74
Shareholders’ Equity Per Share
4.90 4.32 3.99 3.77 3.26
Tax and Other Ratios
Effective Tax Rate
0.13 0.19 0.16 0.14 0.15
Revenue Per Share
3.34 3.00 2.70 2.42 1.84
Net Income Per Share
0.59 0.54 0.59 0.68 0.52
Tax Burden
0.88 0.80 0.81 0.90 0.89
Interest Burden
1.04 0.92 0.96 0.93 0.92
Research & Development to Revenue
0.05 0.05 0.06 0.04 0.03
SG&A to Revenue
0.12 0.12 0.09 0.11 0.11
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.80 1.29 0.92 0.88 0.99
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis